Document is current
Any future updates will be listed below
-
Authors
Abrahamsen, Bendik Skarre
Knudtsen, Ingerid Skjei https://orcid.org/0000-0001-9313-2878
Tulipan, Andreas Julius
Hernes, Eivor
Bogsrud, Trond Velde
Selnæs, Kirsten Margrete
Johansen, Håkon
Bathen, Tone Frost
Elschot, Mattijs
-
Funding
Funding for this research was provided by:
Trond Mohn stiftelse
- License Information
-
More Information
Article History
Received: 14 January 2025
Revised: 17 February 2026
Accepted: 11 March 2026
First Online: 23 April 2026
Compliance with ethical standards
:
: The scientific guarantor of this publication is Tone Frost Bathen.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval was given by the Regional Committees for Medical and Health Research Ethics (REC). For the retrospective cohort, REC waived the need for signed informed consents (REC 10473), while for the prospective cohort, signed informed consents were collected for all patients (REC 83009).
: The retrospective cohort has been previously reported in the added value of [18F]PSMA-1007 PET/CT and PET/MRI in patients with biochemically recurrent prostate cancer: impact on detection rates and clinical management. J Magn Reson Imaging 61:466–477. . The abstract of this work was and is available pre-publication at: .
